Spotlight
Money Desk
Obituaries
Classifieds
Families First
News
Weather
Specialists
Sports
Business
Opinion
Consumer
Health
Life
Out & About
Login
Recommended
Former Holly Hill employees share concerns about patient safety, citing escapes and understaffing
Recommended
Dix Park sunflowers in full bloom. Here's what you need to know
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
Dow Jones Industrial Average
Nasdaq Composite
Standard & Poors 500
Gold
Crude Oil
Local Stocks
WRALTechWire 30
WRALTechWire 30
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Cassava Sciences Inc
(NQ:
SAVA
)
9.840
-0.380 (-3.72%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Jul 8, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Headline News about Cassava Sciences Inc
< Previous
1
2
...
5
6
7
8
9
10
11
12
13
...
18
19
Next >
Take Full Advantage of Weakness in Cassava Sciences Stock
April 26, 2022
Cassava could run back to $40 again. Should the company get a positive nod for its Alzheimer’s treatment, it could see $140 again.
Via
InvestorPlace
Cassava Sciences Is a Worthwhile Bet to Consider
April 25, 2022
FDA approval for Simufilam and successful trials of a new blood test to detect Alzheimer's disease could help propel SAVA stock back up.
Via
InvestorPlace
The Crowd Has Wisely Soured on Cassava Sciences Stock
April 20, 2022
Recent headlines suggest Simulfilam has a slim chance of obtaining FDA approval, justifying the move of SAVA stock to lower prices.
Via
InvestorPlace
12 Health Care Stocks Moving In Tuesday's Intraday Session
April 19, 2022
Gainers Checkmate Pharmaceuticals (NASDAQ:CMPI) stock increased by 331.9% to $10.41 during Tuesday's regular session. Trading volume for Checkmate Pharmaceuticals'...
Via
Benzinga
$1000 Invested In Cassava Sciences 5 Years Ago Would Be Worth This Much
April 19, 2022
Cassava Sciences (NASDAQ:SAVA) has outperformed the market over the past 5 years by 19.11% on an annualized basis producing an average annual return of 32.41%. Currently, Cassava Sciences has a market...
Via
Benzinga
Why Is Cassava Sciences (SAVA) Stock Down Today?
April 19, 2022
SAVA stock is tumbling after The New York Times reported that multiple experts are skeptical about Cassava's data and its main theory.
Via
InvestorPlace
54 Biggest Movers From Yesterday
April 20, 2022
Gainers Checkmate Pharmaceuticals, Inc. (NASDAQ: CMPI) shares jumped 325.9% to close at $10.35 on Tuesday after Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) announced a deal to...
Via
Benzinga
38 Stocks Moving In Tuesday's Mid-Day Session
April 19, 2022
Gainers Checkmate Pharmaceuticals, Inc. (NASDAQ: CMPI) climbed 329.2% to $10.43 after Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) announced a deal to acquire the company for $...
Via
Benzinga
Stocks That Hit 52-Week Lows On Tuesday
April 19, 2022
On Tuesday, 242 companies hit new 52-week lows. Noteworthy Mentions In Today's 52-Week Lows: The largest company in terms of market cap to set a new 52-week low was...
Via
Benzinga
Why Is ToughBuilt Industries (TBLT) Stock Up 65% Today?
April 19, 2022
ToughBuilt Industries (TBLT) stock is rocketing higher Tuesday following the release of the company's Q4 2021 earnings report.
Via
InvestorPlace
Why Is Johnson & Johnson (JNJ) Stock in Focus Today?
April 19, 2022
Johnson & Johnson (JNJ) stock is on the move Tuesday as investors react to the company's earnings report for the first quarter of 2022.
Via
InvestorPlace
New York Times Report Fresh Allegations On Cassava's Simufilam Alzheimer's Trials, Shares Fall
April 19, 2022
Cassava Sciences Inc (NASDAQ: SAVA) shares are shedding over 20% after
Via
Benzinga
Benzinga's Daily Brief On Trending Tickers For April 19, 2022: Plug Power, Twitter, Cassava Sciences And More
April 19, 2022
Benzinga’s “Daily Brief On Trending Tickers” features top-searched tickers from around the web and uses the Benzinga Pro platform to highlight recent news items...
Via
Benzinga
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
April 19, 2022
Gainers Checkmate Pharmaceuticals (NASDAQ:CMPI) shares increased by 331.5% to $10.4 during Tuesday's pre-market session. The market value of their outstanding shares...
Via
Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday
April 19, 2022
Good morning! It's time to start off another busy day of trading with a dive into the biggest pre-market stock movers for Tuesday!
Via
InvestorPlace
23 Stocks Moving in Tuesday's Pre-Market Session
April 19, 2022
Gainers ToughBuilt Industries, Inc. (NASDAQ: TBLT) rose 44.9% to $0.2125 in pre-market trading as the company posted a narrower FY21 loss. Sharps Technology, Inc. (NASDAQ: STSS...
Via
Benzinga
How Is The Market Feeling About Cassava Sciences Inc?
April 13, 2022
Cassava Sciences Inc's (NASDAQ:SAVA) short percent of float has fallen 3.25% since its last report. The company recently reported that it has 10.93 million shares sold short,...
Via
Benzinga
Cassava Sciences Is Worth Considering After Hitting Its Latest Trough
April 11, 2022
The company has no debt and is cash rich. If it receives FDA approval for its Simufilam drug, the SAVA stock price will catapult.
Via
InvestorPlace
Dear SOFI Stock Fans, Mark Your Calendars for May 1
April 05, 2022
SoFi Technologies (SOFI) stock is slipping on Tuesday and may see further falls this week ahead of student loan moratorium news.
Via
InvestorPlace
This Is What Whales Are Betting On Cassava Sciences
April 05, 2022
A whale with a lot of money to spend has taken a noticeably bullish stance on Cassava Sciences. Looking at options history for Cassava Sciences (NASDAQ:SAVA) we detected 14 strange trades.
Via
Benzinga
51 Biggest Movers From Yesterday
April 06, 2022
Gainers Sunshine Biopharma, Inc. (NASDAQ: SBFM) shares surged 148.2% to close at $5.61 on Tuesday after the company announced that two of its designed mRNA molecules are...
Via
Benzinga
Why Is Cassava Sciences (SAVA) Stock Down Today?
April 05, 2022
Cassava Sciences (SAVA) stock is falling on Tuesday as investors react to a recent fireside chat held by CEO Remi Barbier.
Via
InvestorPlace
Here's How Much You Would Have Made Owning Cassava Sciences Stock In The Last 5 Years
April 04, 2022
Cassava Sciences (NASDAQ:SAVA) has outperformed the market over the past 5 years by 29.74% on an annualized basis producing an average annual return of 43.85%. Currently, Cassava Sciences has a market...
Via
Benzinga
Risk-on Biotech Investors Should Buy Cassava Sciences
March 30, 2022
SAVA stock is volatile but worthwhile after opinion shifts in its favor. Remember, it has a blockbuster Alzheimer's drug nearing launch.
Via
InvestorPlace
Here's How Much $100 Invested In Cassava Sciences 5 Years Ago Would Be Worth Today
March 16, 2022
Cassava Sciences (NASDAQ:SAVA) has outperformed the market over the past 5 years by 26.48% on an annualized basis. Buying $100 In SAVA: 5 years ago, an investor could have...
Via
Benzinga
Keep Risk in Mind With Cassava Sciences Stock, but Don’t Dismiss Upside Potential
March 15, 2022
A recent admission by management underscores the need to make SAVA stock, at best, a small, speculative position in your portfolio.
Via
InvestorPlace
Cassava Sciences Is in a Bleak Midwinter Waiting for Spring and Better Days
March 03, 2022
SAVA stock is driven by updates on clinical Phase 3 trials and lots of irrationality. Meanwhile, an FDA approval may take quite some time.
Via
InvestorPlace
12 Health Care Stocks Moving In Wednesday's After-Market Session
March 02, 2022
Gainers Eargo (NASDAQ:EAR) shares rose 10....
Via
Benzinga
Why Cassava Sciences Is Still a High-Risk Play
February 25, 2022
As it's not set in stone that Cassava Sciences will be able to bring simulfilam to market, you should approach SAVA stock cautiously.
Via
InvestorPlace
23 Stocks Moving in Wednesday's Pre-Market Session
February 23, 2022
Gainers Revelation Biosciences, Inc. (NASDAQ: REVB) rose 64.9% to $2.54 in pre-market trading after gaining around 5% on Tuesday. Roth Capital recently initiated coverage on the...
Via
Benzinga
< Previous
1
2
...
5
6
7
8
9
10
11
12
13
...
18
19
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.